Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.
2.

Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables.

Mauri MC, Vita A, Giobbio GM, Ferrara A, Dieci M, Bitetto A, Altamura AC.

Int Clin Psychopharmacol. 1994 Spring;9(1):3-7.

PMID:
8195579
3.

Subjective response to neuroleptics in schizophrenia.

Awad AG.

Schizophr Bull. 1993;19(3):609-18.

PMID:
7901897
4.

Rating of medication influences (ROMI) scale in schizophrenia.

Weiden P, Rapkin B, Mott T, Zygmunt A, Goldman D, Horvitz-Lennon M, Frances A.

Schizophr Bull. 1994;20(2):297-310.

PMID:
7916162
5.

[Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].

Langlois-Thery S, Dollfus S, Lesieur P, Petit M.

Encephale. 1994 Sep-Oct;20(5):487-93. French.

PMID:
7828511
6.

Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement.

Bartkó G, Herczeg I, Békésy M.

J Clin Psychiatry. 1987 Sep;48(9):363-5.

PMID:
3624207
7.

Early subjective response and prediction of outcome to neuroleptic drug therapy in schizophrenia.

Hogan TP, Awad AG, Eastwood MR.

Can J Psychiatry. 1985 Jun;30(4):246-8.

PMID:
2861887
8.

Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point.

Van Putten T, May PR.

Arch Gen Psychiatry. 1978 Apr;35(4):477-80.

PMID:
727898
9.

Subjective response to antipsychotic drugs: failure to replicate predictions of outcome.

Ayers T, Liberman RP, Wallace CJ.

J Clin Psychopharmacol. 1984 Apr;4(2):89-93.

PMID:
6707245
10.

The measurement of subjective experience in schizophrenia: the Subjective Deficit Syndrome Scale.

Jaeger J, Bitter I, Czobor P, Volavka J.

Compr Psychiatry. 1990 May-Jun;31(3):216-26.

PMID:
2340716
11.

Two factors of experienced deficits in schizophrenia and their relationships with positive, negative, and depressive symptoms.

Iwawaki A, Narushima K, Ota K, Okura T, Tsuchiya K, Takashima A.

Compr Psychiatry. 1998 Nov-Dec;39(6):386-91.

PMID:
9829147
12.

Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia.

Goldman RS, Tandon R, Liberzon I, Goodson J, Greden JF.

Psychopathology. 1991;24(4):247-52.

PMID:
1754657
13.

[Value of neuroleptic therapy in the self assessment of schizophrenic patients].

Heim M.

Psychiatr Neurol Med Psychol (Leipz). 1987 Aug;39(8):487-91. German.

PMID:
3685210
14.

Early treatment events and prediction of response to neuroleptics in schizophrenia.

Awad AG, Hogan TP.

Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):585-8.

PMID:
2868492
15.

The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

Marder SR, Davis JM, Chouinard G.

J Clin Psychiatry. 1997 Dec;58(12):538-46. Erratum in: J Clin Psychiatry 1998 Apr;59(4):200.

PMID:
9448657
16.

Prediction of drug responses in schizophrenia: a method using a test dose of chlorpromazine.

Minami H, Nakahara T, Miyahara A, Nakane Y.

Psychiatry Clin Neurosci. 1997 Aug;51(4):217-22.

17.

Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial.

Kramer MS, Vogel WH, DiJohnson C, Dewey DA, Sheves P, Cavicchia S, Little P, Schmidt R, Kimes I.

Arch Gen Psychiatry. 1989 Oct;46(10):922-8.

PMID:
2679483
18.

Subjective response to neuroleptics: the effect of a questionnaire about neuroleptic side effects.

Taira M, Hashimoto T, Takamatsu T, Maeda K.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):1139-42. Epub 2006 Jun 12.

PMID:
16765499
19.

Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.

Harvey PD, Davidson M, White L, Keefe RS, Hirschowitz J, Mohs RC, Davis KL.

Biol Psychiatry. 1996 Oct 15;40(8):755-60.

PMID:
8894068

Supplemental Content

Support Center